GOP Senator Says Alabama's Medical Marijuana Rollout Is 'Corrupt Or Incompetent' And That Cannabis Is Not Medicine

Zinger Key Points
  • ‘I'd like to know how many dollars that have been spent already just trying to get it off the ground,’ State Senator Larry Stutts said. 
  • Stutt's comments come after the HHS recommendation to the DEA to reclassify cannabis confirming some medical value of the plant. 

Alabama legalized medical marijuana in 2021. Fast-forward three years later, the industry suffered a series of setbacks including several lawsuits and challenges, due to the limited number of cannabis licenses and disputes over rightful recipients.

One of the fiercest cannabis opponents in Alabama's legislature, State Senator Larry Stutts (R) recently commented on the industry, continuing to express his criticism. 

“This is just a setup for corruption,” he said during an interview with Mobile radio FM Talk 106.5’s “The Jeff Poor Show.”

“They’re either … corrupt or incompetent in how this is being rolled out. I mean, what’s it been, three years? I’d like to know how many dollars that have been spent already just trying to get it off the ground. I’m still opposed to it." 

Stutts added he doesn't believe that legal medical marijuana is good public policy or that cannabis is indeed good medicine. 

"I think drugs in general are a tremendous problem in our society. To call it ‘medical marijuana’ — it is going to make it more available in society. It is going to legitimize it to young people. ‘This is a medicine.’ It’s not. It’s marijuana. I’m still opposed to it for all those reasons.”

Stutts was the main sponsor of a bill approved by the Alabama Senate in 2022 that requires that all women between the ages of 13 and 50 to prove that they are not pregnant and not breastfeeding to buy medical cannabis.

The Republican senator's comments come after the Department of Health and Human Services (HHS) recommended the DEA to reclassify cannabis to Schedule III under the federal Controlled Substances Act (CSA). Rescheduling marijuana to Schedule III would acknowledge some of its medical values and make it the same type of substance as Tylenol, ketamine, anabolic steroids and testosterone.

See Also: Medical Marijuana Improves Chronic Depression Symptoms, New Clinical Study By German Psychiatric Hospital Shows 

Currently, 40 states plus the District of Columbia have legalized medical marijuana in some form.

Gambling Comparison

The state senator went on to draw a parallel, stating that legalizing gambling would lead to a similar “catastrophe.”

“The rollout has just been a catastrophe, and if you objectively look at how it was going to be rolled out three years ago, you could see that coming — and that’s the same situation with gaming,” Stutt said. “Who is going to run it? Where are the facilities going to be located? How is it going to be managed? Who is going to decide who gets what? Those two issues are a mirror image of each other. You think a marijuana dispensary license is a big deal? Try getting a casino license. And see how big of a deal that is.”

Related Links: 

Third Time Was Not The Charm: Alabama Judge Blocks Medical Marijuana Permits 

Setback Strikes Alabama’s Medical Cannabis Industry, Licenses On Hold Yet Again 

Benzinga Cannabis Conferences are coming to Los Angeles. Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape and shape the evolving markets in California and beyond. Don't miss this chance to be at the forefront of the cannabis industry's growth and innovation! Join now.

Photo: Courtesy of FabrikaSimf via Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsTop StoriesMarketsAlabama CannabisAlabama Medical MarijuanaLarry StuttsStories That Matter
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.